Micro-Cap Review Magazine Spring/Summer 2012

Page 37

WHY MARYLAND? Home to more than 500 life science companies, 50 research-intense federal institutes and academic centers including the FDA, NIH, NIST, and the Johns Hopkins University, Maryland is well positioned to lead the global bioscience industry and is recognized as one of the top bio states for development.

MARYLAND’S LEADERS & INNOVATORS Maryland’s diverse biotechnology industry turns research into reality with cutting-edge discovery, research and development in genomics, bioinformatics, proteomics, therapeutics and diagnostics, research tools, medical devices and more. • Aeras Global TB Vaccine Foundation • Emergent BioSolutions • GlycoMimetics • Human Genome Sciences • Life Technologies • Lonza • Martek Biosciences/DSM • MacroGenics • MedImmune • Pharmathene • QIAGEN • Terumo • United Therapeutics • Westat • Zyngenia

MARYLAND BIOTECHNOLOGY CENTER

Looking to start, expand or relocate a business? Visit MarylandBioCenter.org or call a biotechnology representative at the Center’s Baltimore office (410-767-0505) or Rockville office (301-762-9214).

Martin O’Malley, Governor | Anthony G. Brown, Lt. Governor

The state’s “one-stop shop” for information and resources about Maryland’s biotechnology industry. The center assists biotechnology companies; academic, federal and industry innovators with promotion, connections, site selection; and access to potential partners, clients, sources of capital, and other resources.


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.